Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2013Journal of Leukocyte BiologyOpen Access

CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJill M. KramerEKEkaterina KlimatchevaTRThomas L. Rothstein

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kramer et al. (2013) studied this question.

synapsesocial.com/papers/6a89953da7eee2293bcb00b3https://doi.org/10.1189/jlb.0113036
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lymphoid Chemokine B Cell-Attracting Chemokine-1 (CXCL13) Is Expressed in Germinal Center of Ectopic Lymphoid Follicles Within the Synovium of Chronic Arthritis Patients2001 · 281 citations
  2. 2Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome2002 · 812 citations
  3. 3American College of Rheumatology classification criteria for Sjögren's syndrome: A data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort2012 · 1,367 citations
  4. 4Mature antigen‐experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint2008 · 152 citations